Clinical Trial Details
EORTC-62993
Back to Clinical Trials Database
A phase II study to evaluate the role of weekly Cisplatin with oral Etoposide in Ewing's sarcoma and primitive neuroectodermal tumour (PNET) with metastasis outside the lung and the pleura.
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 12-Jan-2001 Date Step1 close: 02-Dec-2002 |
| Data management at EORTC | Yes |
| Design |
Phase 2 Randomized open label |
| Targeted Sample size | EORTC Groups: 45 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/NCT00014313 |
| NCT number | NCT00014313 |
